Aarti Pharmalabs Ltd
Ticker: AARTIPHARM
Decent
66/100
☆ Add to Watchlist
Investing Reference
Price
836.75
Market Cap
7584.40
Debt/Equity
0.2076
ROE %
14.539
PB
3.8114
Promoter %
43.722
Pledge %
0.003
1Y Rev Growth %
14.411
5Y Rev Growth %
NP Margin %
12.817
NP Margin 5Y Avg %
Trading Reference
1M Return %
-10.837
6M Return %
17.282
1Y Return %
31.337
% Away 52W High
16.044
% Away 52W Low
50.211
Daily Volume
140362
Investment Verdict
Hold
Score 66/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 40/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Aarti Pharmalabs Ltd is currently trading near a key support level, with recent price action showing increased volume on upward movements. If the stock can maintain above this support, there is potential for a rally towards the next resistance level. However, if it breaks below support, it could face significant downside risk.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
S
Strides Pharma Science Ltd
Strides Pharma Science Ltd shows potential but faces challenges in growth consistency and market competition.
View details
R
Religare Enterprises Ltd
Religare Enterprises Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
SBI Nifty 50 ETF
The SBI Nifty 50 ETF is a decent investment option, reflecting the overall health of the Indian economy and its large-cap companies.
View details
B
BHARAT Bond ETF-April 2023-Growth
The BHARAT Bond ETF shows moderate potential but is hindered by several risks and valuation concerns.
View details
N
Network18 Media & Investments Ltd
Network18 Media & Investments Ltd faces significant challenges in growth and profitability, making it a risky investment at this time.
View details
G
GMR Power and Urban Infra Ltd
GMR Power and Urban Infra Ltd shows potential in a growing sector, but faces challenges in profitability and balance sheet strength.
View details
E
ELANTAS Beck India Ltd
ELANTAS Beck India Ltd shows decent fundamentals with consistent growth, but faces challenges in valuation and governance aspects.
View details
C
Campus Activewear Ltd
Campus Activewear Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
C
Cera Sanitaryware Ltd
Cera Sanitaryware Ltd shows decent potential for growth and profitability, but investors should be cautious of valuation and execution risks.
View details
K
Kalpataru Ltd
Kalpataru Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
G
Gujarat State Fertilizers & Chemicals Ltd
Gujarat State Fertilizers & Chemicals Ltd shows decent potential but faces several challenges that could impact future performance.
View details
S
Shilpa Medicare Ltd
Shilpa Medicare Ltd shows potential for growth, but faces challenges in profitability and execution risks.
View details
M
Manorama Industries Ltd
Manorama Industries Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
T
Thomas Cook (India) Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Raymond Lifestyle Ltd
Raymond Lifestyle Ltd is facing several challenges that may hinder its growth potential, making it a risky investment at this time.
View details
P
P N Gadgil Jewellers Ltd
P N Gadgil Jewellers Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Aarti Pharmalabs Ltd is a leading player in the Indian pharmaceutical industry, specializing in the development and manufacture of active pharmaceutical ingredients (APIs) and intermediates. Catering to global pharmaceutical companies, Aarti Pharmalabs is committed to quality, innovation, and sustainability. The company’s focus on research and development ensures it stays ahead in a competitive market, making it a trusted partner for healthcare solutions. With a robust supply chain and a commitment to regulatory compliance, Aarti Pharmalabs plays a crucial role in enhancing healthcare outcomes.
- Leading manufacturer of APIs and intermediates
- Strong focus on research and development
- Commitment to quality and regulatory compliance
- Sustainable practices in production
- Trusted partner for global pharmaceutical companies
Investment Thesis
Aarti Pharmalabs Ltd stands out with a robust promoter group ensuring credibility and strategic direction. The company's focus on digital services presents significant growth potential, aligning with industry trends. Additionally, its attractive valuation compared to peers makes it an appealing choice for investors seeking long-term gains.
- Strong credibility backed by an experienced promoter group.
- Significant growth potential in digital services sector.
- Attractive valuation compared to industry peers.
- Consistent financial performance and robust fundamentals.
- Strategic positioning for future market expansion.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceuticals
- Expansion into international markets
- Strong R&D capabilities
- Government support for healthcare
- Diversified product portfolio
Risks ⚠️
- Regulatory challenges
- Intense market competition
- Currency fluctuations
- Supply chain disruptions
- Rising raw material costs
Peer Perspective
Aarti Pharmalabs Ltd trades at a discount to peers like Sun Pharmaceutical and Dr. Reddy's Laboratories, primarily due to margin volatility; a sustained improvement in margins could trigger a rerating in its valuation.
Future Outlook
Aarti Pharmalabs Ltd is well-positioned for growth, driven by its innovative product pipeline and expanding market presence; however, successful execution and effective cost control will be crucial to fully realize its potential.
AI FAQs for Retail Users
- Q: What does Aarti Pharmalabs Ltd do?A: Aarti Pharmalabs Ltd is a pharmaceutical company focused on manufacturing and supplying active pharmaceutical ingredients and formulations.
- Q: Is Aarti Pharmalabs Ltd listed on stock exchanges?A: Yes, Aarti Pharmalabs Ltd is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) in India.
- Q: What are the key markets for Aarti Pharmalabs Ltd?A: The company primarily operates in domestic and international markets, serving various pharmaceutical sectors.
- Q: What should I consider before investing in Aarti Pharmalabs Ltd?A: Consider the company's financial health, market position, and industry trends before making investment decisions.
- Q: How can I stay updated on Aarti Pharmalabs Ltd?A: You can follow their official website, financial news, and stock market updates for the latest information.
📊 Stock Investment Checklist (100 Points)
Aarti Pharmalabs Ltd • Updated: 2025-09-16 19:12:42
-
10BusinessHighPharmaceutical sector is essential and growing, but competition is intense.
-
10GrowthHighConsistent revenue growth over the past few years, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is inconsistent.
-
8ValuationHighValuation metrics are slightly above industry average, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity ratios are on the lower side.
-
6GovernanceGoodPromoter holding is strong, but there are concerns about pledging.
-
5DriversGoodGrowth drivers exist, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 66 / 100
• Decent
Aarti Pharmalabs Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100